OUR VISION OF THE FUTURE: Arizona is a top-ten life science state.

OUR MISSION: AZBio supports the needs of Arizona’s growing life science ecosystem.

Arizona’s bioscience industry employed 40,399 in 2023 across 3,652 state business establishments, representing a rapid 24.6 percent increase in employment since 2019 and placing the state among the leaders in employment growth. The average wage in the bioscience industry was $102,161—53 percent higher than the state’s private sector average. Academic R&D expenditures in bioscience fields reached a new height of $683.3 million in 2022. NIH funding for Arizona totaled $366.5 million in 2023 following steady annual growth since 2019. Arizona’s bioscience companies attracted strong venture capital investment, with $281.8 million invested in 2023. Arizona stands out in patent activity in bioscience-related technology areas—its 3,387 patent awards from 2019 through 2023 places the state in the second quintile among all states. AZ-BIO2024 - state profile

A key component in Arizona’s life science ecosystem, the Arizona Bioindustry Association (AZBio) is the only statewide organization exclusively focused on growing Arizona’s bioscience industry.

AZBio Member Organizations in the fields of business, research and education, health care delivery, economic development, government, and other professions involved in the biosciences are the key drivers of the growth of Arizona's life science sector. As the unified voice of our industry in Arizona, AZBio strives to make Arizona a place where bioscience organizations can grow and succeed.

AZBio works nationally and globally with the Advanced Medical Technology Association (AdvaMed), the Biotechnology Innovation Organization (BIO), the Medical Device Manufacturers Association (MDMA), the Pharmaceutical Research and Manufacturers of America (PhRMA), and leading patient advocacy organizations.

Through these relationships, AZBio has access to information, contacts, resources, cost saving programs, and the global bioscience and medtech community.

UA researchers have identified a previously unknown mutation in a sodium channel protein as the likely cause of a severe form of epilepsy.

Genome Sequencing Finds Unknown Cause of Epilepsy University of Arizona researchers have identified a previously unknown mutation in a sodium channel protein as the likely cause of a severe form of epilepsy.

Arizona Bioscience: Moving Forward Faster for Ten Years

2012 marks Arizona’s state centennial year. It is also the tenth year of Arizona’s Bioscience Road Map and the anniversary of the launch of TGen (The Translational Genomics Institute.) Employment in the biosciences field in Arizona has grown 41 percent over the past 10 years, showing growth even during the Recession. Ted Simon of HORIZON […]

1,000th Implant of the World’s Only Approved Total Artificial Heart Performed

SynCardia Systems, Inc., manufacturer of the SynCardia temporary Total Artificial Heart, announced today that the 1,000th implant of the world’s first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart was performed on Feb. 10 at The University of Arizona Medical Center in Tucson, AZ. Since then, an additional four implants of […]

ASU helps state attract venture capital for high-technology firms

ASU News: 02/23/2012 Heliae, a technology-development company based in Chandler, is working to design an industrial process that starts with the creation of high-fat strains of algae and ends with the production of jet fuel and other commercial products. Fluidic Energy, located in Scottsdale, is dedicated to transforming the way electricity is generated, delivered and […]